Comparability of the Australian National Cancer Symptom Trials (CST) Group's Study Populations to National Referrals to Non-CST Specialist Palliative Care Services Participating in the Palliative Care Outcomes Collaboration

Hiromichi Matsuoka; Samuel Allingham; Belinda Fazekas; Linda Brown; Zac Vandersman; Katherine Clark; Meera R. Agar; David C. Currow

doi:10.1016/j.jpainsymman.2018.09.017

Comparability of the Australian National Cancer Symptom Trials (CST) Group's Study Populations to National Referrals to Non-CST Specialist Palliative Care Services Participating in the Palliative Care Outcomes Collaboration

Hiromichi Matsuoka, Samuel Allingham, Belinda Fazekas, Linda Brown, Zac Vandersman, Katherine Clark, Meera R. Agar, David C. Currow

Research output: Contribution to journal › Letter › peer-review

2 Citations (Scopus)

25 Downloads (Pure)

Abstract

Introduction
Using the results of Phase III studies in clinical practice depends on how representative study participants are of the clinical population to whom the results will be applied. The closer the characteristics between the subgroup who participate in a clinical trial and the whole population, the easier it is for clinicians to apply the results directly to the patient that he/she is treating. Trial participation is generally more happenstance than a systematic sampling of a population and is limited by eligibility criteria that do not reflect the entire clinical population

Original language	English
Pages (from-to)	e9-e14
Number of pages	6
Journal	Journal of Pain and Symptom Management
Volume	57
Issue number	1
DOIs	https://doi.org/10.1016/j.jpainsymman.2018.09.017
Publication status	Published - Jan 2019
Externally published	Yes

Bibliographical note

Under a Creative Commons license CC BY-NC-ND

Keywords

comorbidities
palliative care
Phase IV postmarketing studies

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.jpainsymman.2018.09.017Licence: CC BY-NC-ND

Fazekas_Comparability_P2019Final published version, 187 KBLicence: CC BY-NC-ND

Fingerprint

Dive into the research topics of 'Comparability of the Australian National Cancer Symptom Trials (CST) Group's Study Populations to National Referrals to Non-CST Specialist Palliative Care Services Participating in the Palliative Care Outcomes Collaboration'. Together they form a unique fingerprint.

Cite this

Matsuoka, H., Allingham, S., Fazekas, B., Brown, L., Vandersman, Z., Clark, K., Agar, M. R., & Currow, D. C. (2019). Comparability of the Australian National Cancer Symptom Trials (CST) Group's Study Populations to National Referrals to Non-CST Specialist Palliative Care Services Participating in the Palliative Care Outcomes Collaboration. Journal of Pain and Symptom Management, 57(1), e9-e14. https://doi.org/10.1016/j.jpainsymman.2018.09.017

Matsuoka, Hiromichi ; Allingham, Samuel ; Fazekas, Belinda et al. / Comparability of the Australian National Cancer Symptom Trials (CST) Group's Study Populations to National Referrals to Non-CST Specialist Palliative Care Services Participating in the Palliative Care Outcomes Collaboration. In: Journal of Pain and Symptom Management. 2019 ; Vol. 57, No. 1. pp. e9-e14.

@article{25596fb5e2974832aeb7800358c4efdc,

title = "Comparability of the Australian National Cancer Symptom Trials (CST) Group's Study Populations to National Referrals to Non-CST Specialist Palliative Care Services Participating in the Palliative Care Outcomes Collaboration",

abstract = "IntroductionUsing the results of Phase III studies in clinical practice depends on how representative study participants are of the clinical population to whom the results will be applied. The closer the characteristics between the subgroup who participate in a clinical trial and the whole population, the easier it is for clinicians to apply the results directly to the patient that he/she is treating. Trial participation is generally more happenstance than a systematic sampling of a population and is limited by eligibility criteria that do not reflect the entire clinical population",

keywords = "comorbidities, palliative care, Phase IV postmarketing studies",

author = "Hiromichi Matsuoka and Samuel Allingham and Belinda Fazekas and Linda Brown and Zac Vandersman and Katherine Clark and Agar, {Meera R.} and Currow, {David C.}",

note = "Under a Creative Commons license CC BY-NC-ND",

year = "2019",

month = jan,

doi = "10.1016/j.jpainsymman.2018.09.017",

language = "English",

volume = "57",

pages = "e9--e14",

journal = "Journal of Pain and Symptom Management",

issn = "0885-3924",

publisher = "Elsevier Inc.",

number = "1",

}

Matsuoka, H, Allingham, S, Fazekas, B, Brown, L, Vandersman, Z, Clark, K, Agar, MR & Currow, DC 2019, 'Comparability of the Australian National Cancer Symptom Trials (CST) Group's Study Populations to National Referrals to Non-CST Specialist Palliative Care Services Participating in the Palliative Care Outcomes Collaboration', Journal of Pain and Symptom Management, vol. 57, no. 1, pp. e9-e14. https://doi.org/10.1016/j.jpainsymman.2018.09.017

Comparability of the Australian National Cancer Symptom Trials (CST) Group's Study Populations to National Referrals to Non-CST Specialist Palliative Care Services Participating in the Palliative Care Outcomes Collaboration. / Matsuoka, Hiromichi; Allingham, Samuel; Fazekas, Belinda et al.
In: Journal of Pain and Symptom Management, Vol. 57, No. 1, 01.2019, p. e9-e14.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Comparability of the Australian National Cancer Symptom Trials (CST) Group's Study Populations to National Referrals to Non-CST Specialist Palliative Care Services Participating in the Palliative Care Outcomes Collaboration

AU - Matsuoka, Hiromichi

AU - Allingham, Samuel

AU - Fazekas, Belinda

AU - Brown, Linda

AU - Vandersman, Zac

AU - Clark, Katherine

AU - Agar, Meera R.

AU - Currow, David C.

N1 - Under a Creative Commons license CC BY-NC-ND

PY - 2019/1

Y1 - 2019/1

N2 - IntroductionUsing the results of Phase III studies in clinical practice depends on how representative study participants are of the clinical population to whom the results will be applied. The closer the characteristics between the subgroup who participate in a clinical trial and the whole population, the easier it is for clinicians to apply the results directly to the patient that he/she is treating. Trial participation is generally more happenstance than a systematic sampling of a population and is limited by eligibility criteria that do not reflect the entire clinical population

AB - IntroductionUsing the results of Phase III studies in clinical practice depends on how representative study participants are of the clinical population to whom the results will be applied. The closer the characteristics between the subgroup who participate in a clinical trial and the whole population, the easier it is for clinicians to apply the results directly to the patient that he/she is treating. Trial participation is generally more happenstance than a systematic sampling of a population and is limited by eligibility criteria that do not reflect the entire clinical population

KW - comorbidities

KW - palliative care

KW - Phase IV postmarketing studies

UR - http://www.scopus.com/inward/record.url?scp=85058932536&partnerID=8YFLogxK

U2 - 10.1016/j.jpainsymman.2018.09.017

DO - 10.1016/j.jpainsymman.2018.09.017

M3 - Letter

C2 - 30273716

AN - SCOPUS:85058932536

SN - 0885-3924

VL - 57

SP - e9-e14

JO - Journal of Pain and Symptom Management

JF - Journal of Pain and Symptom Management

IS - 1

ER -

Matsuoka H, Allingham S, Fazekas B, Brown L, Vandersman Z, Clark K et al. Comparability of the Australian National Cancer Symptom Trials (CST) Group's Study Populations to National Referrals to Non-CST Specialist Palliative Care Services Participating in the Palliative Care Outcomes Collaboration. Journal of Pain and Symptom Management. 2019 Jan;57(1):e9-e14. doi: 10.1016/j.jpainsymman.2018.09.017

Comparability of the Australian National Cancer Symptom Trials (CST) Group's Study Populations to National Referrals to Non-CST Specialist Palliative Care Services Participating in the Palliative Care Outcomes Collaboration

Abstract

Bibliographical note

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this